» Articles » PMID: 27305766

Inhibitory Effect of Zinc Sulfide Nanoparticles Towards Breast Cancer Stem Cell Migration and Invasion

Overview
Date 2016 Jun 17
PMID 27305766
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer stem cells are demonstrated to be a highly malignant cancer with an extremely high migratory ability and conventional therapies have little effect on preventing cancer migration and invasion. In this study, we investigated the inhibitory effect of zinc sulfide (ZnS) nanoparticles towards the migration and invasion of breast cancer stem cells MCF-7-SC. The cytotoxicity studies and the Hoechst staining experiments suggested that there is no obvious toxicity of ZnS has been observed upto a concentration of 400 µg/mL. ZnS nanoparticles significantly inhibited the wound healing in the MCF-7-SC cells. The cell invasion assay and western blot analysis results suggested that ZnS nanoparticles inhibited the metastasis of MCF-7-SCs in dose-dependent manner by suppressing epithelial-mesenchymal transition process. Overall, our experimental analysis suggested that nano ZnS has the ability to inhibit cancer stem cell migration and invasion, which can open up new insights in the cancer therapy.

Citing Articles

Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells.

Dey S, Dinakar Y, R S, Jain V, Jain R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39441235 DOI: 10.1007/s00210-024-03542-5.


Investigation of antibacterial and anticancer activities of copper, aluminum and nickel doped zinc sulfide nanoparticles.

Munir T, Mahmood A, Ali I, Abbas N, Sohail A, Arshia Sci Rep. 2024; 14(1):19304.

PMID: 39164280 PMC: 11335939. DOI: 10.1038/s41598-024-68631-0.


Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.

Ali K, Nabeel M, Mohsin F, Iqtedar M, Islam M, Rasool M Med Oncol. 2024; 41(5):112.

PMID: 38592510 DOI: 10.1007/s12032-024-02347-z.


Advances of nanotechnology applied to cancer stem cells.

Yue M, Guo T, Nie D, Zhu Y, Lin M World J Stem Cells. 2023; 15(6):514-529.

PMID: 37424953 PMC: 10324502. DOI: 10.4252/wjsc.v15.i6.514.


The theranostic potentialities of bioavailable nanocurcumin in oral cancer management.

Essawy M, Mohamed M, Raslan H, Rafik S, Awaad A, Ramadan O BMC Complement Med Ther. 2022; 22(1):309.

PMID: 36424593 PMC: 9685877. DOI: 10.1186/s12906-022-03770-3.